This is the last of the three-part podcast series, Keeping up with the Chemos on tisotumab vedotin.  Our multidisciplinary panel will discuss the challenges with patient monitoring while on tisotumab vedotin.  The panel discusses personal clinical experiences and lessons learned.  When to dose adjust and hold or even discontinue tisotumab vedotin. Once again, the session ends with take home points for patient monitoring while on tisotumab vedotin.  

2022-2023 Chemotherapy/Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Judith A. Smith, B.S., Pharm.D, BCOP, CPHQ

Speakers:
Julia Canestraro, OD, FAAO
Shannon Westin, MD 
Erin Hickey Zacholski, Pharm.D